NCT01022476 2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
Clinical Trials
79 trialsNCT07503353 2026-03-31
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Not yet recruiting
NCT07477912 2026-03-17
MSTH-CAR001
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Recruiting
NCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
NCT07334431 2026-01-12
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT06421948 2025-12-05
Linperlisib Combined With Chidamide in Patients With PTCL
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT01089387 2025-12-04
INSTIN
Institut National de la Santé Et de la Recherche Médicale, France
Phase 1/2 Completed
NCT07264569 2025-12-04
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT01992952 2025-11-26
FAKTION
Velindre NHS Trust
Phase 1/2 Active not recruiting
NCT07245381 2025-11-24
Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation
Sheba Medical Center
Phase 1/2 Not yet recruiting
NCT07136545 2025-09-10
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
Taipei Veterans General Hospital, Taiwan
Phase 1/2 Recruiting
NCT07162571 2025-09-09
MSTH-CAR002
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Not yet recruiting
NCT06329973 2025-07-17
Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT03093688 2025-07-02
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Recruiting
NCT06602063 2025-06-27
Surgery for Relapsed Ovarian Cancer in Precision
Shanghai Gynecologic Oncology Group
Phase 1/2 Not yet recruiting
NCT06955390 2025-05-02
Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT06656169 2025-05-01
Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.
Instituto Mexicano del Seguro Social
Phase 1/2 Completed
NCT05359783 2025-03-28
MAGSNOW
Vastra Gotaland Region
Phase 1/2 Completed
NCT06788197 2025-03-26
A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT06880029 2025-03-19
CIRCADIAN
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Phase 1/2 Recruiting
NCT05319639 2025-02-27
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
Fujian Cancer Hospital
Phase 1/2 Recruiting
NCT06299462 2025-02-25
PTCy and ATG for MSD and MUD Transplants
Instituto Nacional de Cancer, Brazil
Phase 1/2 Recruiting
NCT05937438 2025-01-29
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT06790615 2025-01-24
Comparison of Thread Technique Versus Aspiration Plus Steroid Injection for Wrist Ganglion Recurrence
Benazir Bhutto Hospital, Rawalpindi
Phase 1/2 Completed
NCT05176080 2024-12-17
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Henan Cancer Hospital
Phase 1/2 Terminated
NCT05019690 2024-09-19
Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
Fujian Cancer Hospital
Phase 1/2 Recruiting
NCT06527898 2024-09-19
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT06479473 2024-08-09
Radiotherapy to All Residual Lesions After Chemoimmunotherapy
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT05269485 2024-06-25
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT06454890 2024-06-12
Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)
Henan Cancer Hospital
Phase 1/2 Not yet recruiting
NCT03685890 2024-04-25
NivoILP
Vastra Gotaland Region
Phase 1/2 Recruiting
NCT05243212 2024-01-31
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
Sheba Medical Center
Phase 1/2 Recruiting
NCT06136910 2023-11-18
Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer
Fujian Cancer Hospital
Phase 1/2 Unknown
NCT06078670 2023-10-12
PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors
Fujian Cancer Hospital
Phase 1/2 Not yet recruiting
NCT05882630 2023-05-31
Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer
Fujian Cancer Hospital
Phase 1/2 Not yet recruiting
NCT05335473 2023-04-06
Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure
Henan Cancer Hospital
Phase 1/2 Unknown
NCT05429905 2023-03-09
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
KK Women's and Children's Hospital
Phase 1/2 Unknown
NCT01173172 2023-02-22
BNCT
Taipei Veterans General Hospital, Taiwan
Phase 1/2 Completed
NCT05608785 2022-11-08
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Henan Cancer Hospital
Phase 1/2 Unknown
NCT05037539 2022-08-31
Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain
Department of Medical Services Ministry of Public Health of Thailand
Phase 1/2 Completed
NCT03551795 2022-05-09
Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Completed
NCT05254249 2022-02-24
Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris
Dr. Soetomo General Hospital
Phase 1/2 Unknown
NCT05108077 2022-01-14
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Phase 1/2 Unknown
NCT05149339 2021-12-08
Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia
Zagazig University
Phase 1/2 Completed
NCT04834089 2021-04-08
SOROCOV
Butantan Institute
Phase 1/2 Unknown
NCT02772198 2020-11-03
T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies
Sheba Medical Center
Phase 1/2 Unknown
NCT04126655 2020-08-27
Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate
Vastra Gotaland Region
Phase 1/2 Unknown
NCT04386343 2020-08-24
CH1701
Vietlife Healthcare Corporation
Phase 1/2 Unknown
NCT04213898 2019-12-30
SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer
Henan Cancer Hospital
Phase 1/2 Unknown
NCT04199559 2019-12-16
Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer
Henan Cancer Hospital
Phase 1/2 Unknown